In the neoadjuvant setting of melanoma treatment, combination therapy of ipilimumab to nivolumab resulted in severe irAEs reaching up to 90% [6]

In the neoadjuvant setting of melanoma treatment, combination therapy of ipilimumab to nivolumab resulted in severe irAEs reaching up to 90% [6]. would be more common and so irAEs. irAEs…

Continue ReadingIn the neoadjuvant setting of melanoma treatment, combination therapy of ipilimumab to nivolumab resulted in severe irAEs reaching up to 90% [6]

(ACE) and S

(ACE) and S.D. loxP sites (B6.129-Casp8tm1Hed) (backcrossed to C57BL/6J, n 10) (36) were crossed to mice (B6.Cg-Tg(Itgax-cre)1-1Reiz/J) (37) to create mice. These mice are known as mice to create conditional…

Continue Reading(ACE) and S